| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00493462 |
| P698 | PubMed publication ID | 2162156 |
| P50 | author | Tadeusz Chorzelski | Q15129496 |
| Stefania Jabłońska | Q517497 | ||
| P2093 | author name string | G G Maul | |
| M Blaszczyk | |||
| M Jarzabek-Chorzelska | |||
| Z Kolacinska-Strasz | |||
| P2860 | cites work | Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen | Q69901553 |
| Antinuclear antibodies in the relatives of patients with systemic sclerosis | Q69938458 | ||
| Immunobiological significance of the Ro/SSA antigen-antibody system | Q70068538 | ||
| High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients | Q70124748 | ||
| Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis | Q70238267 | ||
| Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants | Q70240365 | ||
| Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis | Q70298686 | ||
| [Nuclear antibodies as serologic markers in progressive systemic scleroderma] | Q70336852 | ||
| The anticentromere antibody: disease specificity and clinical significance | Q70383558 | ||
| A standardized method of detecting antibodies to extractable nuclear antigens (RNP and Sm) by gel precipitation | Q70416651 | ||
| Anticentromere antibodies in primary biliary cirrhosis | Q70440116 | ||
| HLA antigens, autoantibodies and clinical subsets in scleroderma | Q70960365 | ||
| Human anticentromere antibodies: distribution, characterization of antigens, and effect on microtubule organization | Q70995340 | ||
| Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis | Q71002244 | ||
| Anticentromere and anticentriole antibodies in the scleroderma spectrum | Q71758134 | ||
| The CREST syndrome: a distinct serologic entity with anticentromere antibodies | Q72080575 | ||
| Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome | Q72611213 | ||
| The biological and diagnostic significance of antinuclear antibodies | Q72643471 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I | Q28302945 | ||
| Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | Q33553751 | ||
| Anticentromere antibody in primary biliary cirrhosis | Q33553886 | ||
| Serological markers in progressive systemic sclerosis: clinical correlations | Q33554043 | ||
| Characterisation of centromere (kinetochore) antigen reactive with sera of patients with a scleroderma variant (CREST syndrome) | Q33555550 | ||
| Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis | Q33556986 | ||
| Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis | Q34317089 | ||
| Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen | Q34393316 | ||
| Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies | Q34520516 | ||
| Scl-86, a marker antigen for diffuse scleroderma | Q34538340 | ||
| Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase | Q35616800 | ||
| The kinetochore is part of the metaphase chromosome scaffold. | Q36209669 | ||
| Screening cDNA expression libraries with monoclonal and polyclonal antibodies using an amplified biotin-avidin-peroxidase technique | Q36419348 | ||
| Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis | Q39296891 | ||
| Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma | Q41107777 | ||
| Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. | Q44490088 | ||
| Scl 70 antibody--a specific marker of systemic sclerosis. | Q55060807 | ||
| THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY | Q59032616 | ||
| Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma | Q60449657 | ||
| A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis | Q68902005 | ||
| Nucleoprotein autoantibodies in lupus erythematosus | Q68934693 | ||
| Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay | Q69819942 | ||
| Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases | Q69871175 | ||
| Anticentromere antibody: an immunological marker of a subset of systemic sclerosis | Q69875349 | ||
| Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies | Q69883759 | ||
| Anticentromere antibody and immunoglobulin allotypes in scleroderma | Q69885453 | ||
| P433 | issue | 2 | |
| P921 | main subject | antibody | Q79460 |
| immunofluorescence microscopy | Q592324 | ||
| systemic scleroderma | Q5340515 | ||
| P304 | page(s) | 76-83 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Archives of Dermatological Research | Q18616385 |
| P1476 | title | Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion. | |
| P478 | volume | 282 |
| Q40559192 | Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex |
| Q47137522 | CENP-B protects centromere chromatin integrity by facilitating histone deposition via the H3.3-specific chaperone Daxx |
| Q37346550 | Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody |
| Q34498250 | Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis |
| Q41920779 | Immunologic markers of systemic scleroderma in children |
| Q24670576 | PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1 |
| Q72725413 | Significance of in vivo pepper-dot epidermal nuclear reactions: correlation with anticentromere antibodies and CREST syndrome |
| Q24799804 | The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis |
Search more.